Indication
Carmuther is indicated as palliative therapy as a single agent or in combination with other approved chemotherapeutic agents in brain tumors-glioblastoma, Hodgkin’s disease etc.
Note
Precaution
- Carmuther is a prescription drug and should be used under proper medical guidance and advice.
- Carmuther may produce cumulative myelosuppession manifested by more depressed indices.
